老太太成功移植姚贝娜眼角膜:感谢姚姑娘

2016-01-19 贵州都市报 贵州都市报

1月18日,遵义一老太成功移植姚贝娜眼角膜。去年1月16日,著名歌手姚贝娜因罹患乳腺癌不幸去世。按照她的遗愿,逝世当天,医生姚晓明摘取了她 的一对眼角膜,这对眼角膜先后帮助深圳、成都、武汉的三位眼疾患者重见光明。18日,医生姚晓明将姚贝娜剩余的左眼环形边缘眼角膜带到贵阳,移植到遵义县 67岁老太太的双眼上。眼角膜昨日抵达贵阳18日,在贵阳龙洞堡机场,姚晓明怀抱着行李箱出现在接机口。担心角膜有闪失,

1月18日,遵义一老太成功移植姚贝娜眼角膜。去年1月16日,著名歌手姚贝娜因罹患乳腺癌不幸去世。按照她的遗愿,逝世当天,医生姚晓明摘取了她 的一对眼角膜,这对眼角膜先后帮助深圳、成都、武汉的三位眼疾患者重见光明。18日,医生姚晓明将姚贝娜剩余的左眼环形边缘眼角膜带到贵阳,移植到遵义县 67岁老太太的双眼上。

眼角膜昨日抵达贵阳

18日,在贵阳龙洞堡机场,姚晓明怀抱着行李箱出现在接机口。担心角膜有闪失,他一直将存放眼角膜的保温瓶放在随身的行李箱中,直到抵达贵州晶朗眼科医院后,他才将眼角膜保温瓶放入保温箱中。

姚晓明是姚贝娜亲自授权的遗愿执行人。姚贝娜逝世当晚,正是他为其实施了角膜摘除手术。此后对受捐者进行的角膜移植手术也是由他亲自操刀。

像大多数人一样,姚晓明认识姚贝娜也是通过电视荧幕开始的。他告诉记者,他和姚贝娜的父亲姚峰都是深圳市的政协委员,虽然不算深交,但很早就认识。姚峰知道姚晓明是全国著名角膜移植专家。所以当姚贝娜表达出捐献眼角膜的意向后,姚峰第一时间将此事委托给了他。

其实,除了在电视荧幕上见过姚贝娜外,姚晓明第一次亲眼见到她是在一次演唱会后,“不像个大明星,像邻家女孩,很清新的一个姑娘。”姚晓明说,他们第二次见面时,已是姚贝娜离世前几天。

去年1月7日中午,姚晓明意外地接到了姚峰的电话:“贝娜快不行了,我们准备捐献她的角膜。”姚晓明坦言,当时他很震惊,姚贝娜能做出这样的行动,很让人钦佩。

受捐者:感谢善良的姚姑娘

18日上午,记者来到贵州晶朗眼科医院,受捐者罗成珍正在医院做常规检查。罗成珍告诉记者,最近四五年,她的视力变得很差,虽然看得见光,但却看不清楚物体。

罗成珍的儿子陈进军告诉记者,自从母亲眼疾恶化后,他们四处求医,但效果不明显。上周,他带母亲去遵义县人民医院做检查,医生告诉他,必须要做眼角膜移植手术,如果不手术,母亲的角膜将会穿孔,导致失明。

可是哪里有角膜来源呢?“还好家里有个亲戚是眼科医生,亲戚将消息发到网上寻找角膜。”陈进军说,这位亲戚联系到了晶朗眼科,对方告诉她可以帮忙找到眼角膜。几天后,晶朗眼科反馈消息,角膜找到了,可以近期就做手术。他们还告诉受捐者,角膜捐献者名叫姚贝娜。

“我儿子说给我捐眼角膜的是一个大明星,名叫姚贝娜。可我是农村老太太,不认识姚贝娜。她那么年轻就过世了,真的好可惜。感谢这个姚姑娘,她是个心地善良的好人!”罗成珍感叹道。

先移植右眼 左眼年后移植

18 日下午3点,姚晓明亲自操刀,姚贝娜的左眼环形边缘眼角膜被分为两部分,分别植入到老太太的双眼病变处。1个小时20分钟后,手术顺利结束,据晶朗眼科医 生介绍,此次手术成功将眼角膜植入到罗成珍的右眼,1月19日罗成珍就可拆掉纱布观察术后状况了。据了解,罗成珍左眼的眼角膜植入将安排在年后。

为什么会将姚贝娜的眼角膜捐给这位老太太?姚晓明告诉记者,一对眼角膜可以帮助多名患者复明。由于前三次的捐赠移植,姚贝娜的一对眼角膜只剩下左眼环形边缘眼角膜和部分右眼边缘眼角膜。

这位老太太患上的是边缘性角膜病变,两只眼睛的上半部分角膜病变严重。病变严重部位的形状大小都和姚贝娜左眼环形边缘眼角膜吻合,可以将这个完整的角膜分成两半,分别移植到老太太的左右眼上。

姚 晓明告诉记者,眼角膜有3种保存方式,短期的保存方式要求眼角膜必须在取出后的24小时之内就进行移植;中期的保存方式则要求在取出后2周内进行移植。姚 贝娜的眼角膜采用的是长期保存方法,也就是低温冻存法,这种方法理论上可以让眼角膜无限期保存,可以让眼角膜的利用达到最大化。

姚晓明介绍,目前姚贝娜剩下的眼角膜还可以帮助至少两个人复明。

贵州:眼角膜捐赠尚未起步

据贵州晶朗眼科医院董事长吴长恩介绍,目前眼角膜捐赠在贵州的开展还没有起步。估计我省有5万余人等待角膜移植,由于省内缺口过大,眼角膜资源主要来自外省甚至外国。大多数患者因为没有移植眼角膜而导致失明。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-27 李继凯

    赞一个↖(^ω^)↗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-27 李继凯

    正能量

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-27 vinson820801

    赞一个

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-26 doctording1

    正能量!赞

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-21 snowpeakxu
  7. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-20 doctorxia120

    赞那些捐献器官的人

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-20 Qun_er

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-20 xi.xiong

    很棒,赞一个!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2076979, encodeId=705820e697921, content=<a href='/topic/show?id=34a1e2910b1' target=_blank style='color:#2F92EE;'>#眼角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72910, encryptionId=34a1e2910b1, topicName=眼角膜)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jun 21 13:34:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61234, encodeId=dd8a6123467, content=赞一个↖(^ω^)↗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=61233, encodeId=74e9612330f, content=正能量, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Wed Jan 27 19:19:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=60446, encodeId=b92160446a6, content=赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5b91683812, createdName=vinson820801, createdTime=Wed Jan 27 09:58:00 CST 2016, time=2016-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=59439, encodeId=2a8a5943918, content=正能量!赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59121683644, createdName=doctording1, createdTime=Tue Jan 26 14:07:00 CST 2016, time=2016-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349040, encodeId=0eca1349040ed, content=<a href='/topic/show?id=4337909284a' target=_blank style='color:#2F92EE;'>#角膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90928, encryptionId=4337909284a, topicName=角膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu Jan 21 12:34:00 CST 2016, time=2016-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58587, encodeId=d1a55858e70, content=赞那些捐献器官的人, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdc91679416, createdName=doctorxia120, createdTime=Wed Jan 20 23:09:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58497, encodeId=b7645849e55, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800c1638886, createdName=Qun_er, createdTime=Wed Jan 20 09:57:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58496, encodeId=531b58496f2, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:54:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=58495, encodeId=423d58495a1, content=很棒,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6dc1665697, createdName=xi.xiong, createdTime=Wed Jan 20 09:53:00 CST 2016, time=2016-01-20, status=1, ipAttribution=)]
    2016-01-20 xi.xiong

    很棒,赞一个!

    0

相关资讯

猪眼角膜经处理可移植给人

近日,由中国科学家花了十年时间研发的生物工程角膜已完成临床试验上市。该眼角膜是用猪的眼角膜经过处理,再用于人的。医学界预测,生物工程角膜将极大地缓解中国人体捐献角膜奇缺的临床困境,为中国400万乃至全球6000万的角膜盲患者带来复明的希望。 据第四军医大学组织工程研发中心主任金岩教授介绍,艾欣瞳工程眼角膜是由异种角膜(目前是用猪的眼角膜)经脱细胞特殊工艺多级处理的。科学家去除了角膜中的细胞、杂

“好医生”贾永青去世 捐献眼角膜

“因为爱自己的职业,所以爱每一个患者。”6月22日凌晨2时许,年仅32岁的定州市人民医院产科医生贾永青用一种特殊的方式再一次诠释了自己的信念,她的双眼角膜分别捐献给山东和保定清苑的两名患者,从而完成了人生最后的愿望。 6月21日17时许,在定州市人民医院接受治疗的贾永青病情突然恶化,经医务人员全力救治无效,在与病魔顽强抗争了1年零9个月后,于当日22时10分不幸去世。 6月22日2时40分,眼